IL-10 and IL-12p40 in Egyptian Patients with HCV-Related Chronic Liver Disease

¹Howayda Hassoba, ¹Ola Leheta, ¹Amal Sayed, ¹Hanaa Fahmy, ¹Amal Fathy, ²Faten Abbas, ³Fawzi Attia, ³Abdelhamid Serwah

Departments of ¹Clinical Pathology, ²Physiology, ³Medicine, Suez Canal University, Ismailia Egypt.

Hepatitis C virus (HCV) is the leading cause of chronic liver disease worldwide with a prevalence of ~14% in Egypt. IL-10 is a cytokine produced by Th2 cells. It down-regulates the proinflammatory response and modulates hepatic fibrogenesis. IL-12 is produced by antigen presenting cells. It promotes Th1 cell response and has many antiviral properties. Data concerning the Th-1/Th-2 balance in chronic hepatitis C (CH-C) are rather conflicting. Using ELISA, we assessed serum IL-10 and IL-12p40 levels in 66 Egyptian patients with HCV-related liver illness (CH-C, cirrhosis, and HCC), and their relationship to disease activity. Our results showed that spontaneous IL-10 was undetectable in patients with CH-C, HCC or controls. Only 5/22 (23%) of patients with cirrhosis showed detectable levels of IL-10. IL-12p40 was elevated in the patient groups compared to controls (p= 0.01, p= 0.01, p= 0.05 in CH-C, cirrhosis and HCC, respectively). The presence of IL-12p40 was associated with HCV level of viremia and serum AST. Serum ALT level was significantly associated with the level of IL-12p40. IL-12p40 was unrelated to liver histology or fibrosis. We concluded that in the Egyptian patients an augmentation of IL-12p40 and a suppression of IL-10 are both found. Whether this pattern is related to HCV genotype 4, or to the presence of schistosomiasis would need to be further investigated.